Aurobindo Pharma gains 2% on USFDA approval for anti-HIV drug News News / News 7 years ago 568 Views comments The triple combination product is expected to be launched in sub-Saharan Africa in Q3FY18. Read more
News Ashish Kochalia: This multibagger smallcap picker has 19 stock ideas to win big News / News - 7 years ago
News My election as Srinagar Mayor message to those who treat politics as fiefdom: Junaid Mattu News / News - 6 years ago
News Market Live: Nifty opens August series below 10,000, Sensex sheds over 100 pts News / News - 7 years ago
Comments